Arrhythmia & EP Perspective

 
 
  • Pediatricians Should Screen for Anxiety David C. Rettew, MD, discusses next steps in screening children for anxiety.
  • 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.
  • ECG Challenge: Lightheadedness and Extremely Slow Pulse A cardiology patient presents to the emergency department with lightheadedness and a pulse of 30 beats/min. What does his ECG show?
  • Dec 16 2022 This Week in Cardiology   BP control over the long term, omecamtiv mecarbil, incentives and Goodhart’s law, and open science are the topics John Mandrola, MD, covers in this week’s podcast.
  • Top Neurology Studies to Know   Hans-Christoph Diener, MD, PhD, discusses new research in the neurology space in September 2022.
  • Managing Stimulant Use Disorder in Primary Care   In their series on addiction medicine, Curbsiders Dr Carolyn Chan and Dr Natalie Stahl share expert tips on harm reduction, contingency management, and overamping in patients who use stimulants.
  • Mandrola’s Top 10 Cardiology Stories of 2022 A few dogmas felled, wins for meds, an exemplary trial, and clinical trends good and bad are covered in John Mandrola’s annual wrap up of cardiology stories for 2022.
  • Dec 9 2022 This Week in Cardiology   Nudges, statins, AI, less-is-more in the ICU, myocarditis, exercise as medicine, and December in the hospital are the topics John Mandrola, MD, covers in this week’s podcast.
  • CRT in HFrEF Management: Updates Plus 'What's Next?'   Drs Chung and Bhatia discuss the evolution of cardiac resynchronization therapy, guideline recommendations, and emerging technologies.
  • Dec 2 2022 This Week in Cardiology   SGLT2 inhibitors, publishing choices, second and third order effects of interventions, decision support, and patient selection for preventive procedures are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Episode 4: Can Cannabis Help Patients With MS?   Drs Cross and Bainbridge discuss cannabis, safety issues, drug-drug interactions, potential liver toxicity, tolerance, and possible dependency for people living with MS.
  • AHA 2022 Is Finding and Fixing Iron Deficiency in HF Beneficial?   Ileana Piña interviews Paul Kalra about the IRONMAN trial from the American Heart Association which randomized HF patients with iron deficiency to IV ferric derisomaltose repletion or no infusions.
  • ECG Challenge: Irregular Pulse During Cardiology Visit A patient with coronary artery disease and hypertension presents with an irregular pulse. What does the ECG reveal?
  • Starting Lamotrigine: Who Needs an EKG?   Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.
  • Nov 18 2022 This Week in Cardiology   AHA 2022, Part 2: IRONMAN, ECMO-CS, CTS-AMI, and PROGRESSIVE AF are the trials John Mandrola, MD, reviews in this week’s podcast.
  • ME/CFS and Long COVID: Q&A With the CDC's Dr Jennifer Cope The conditions have overlapping symptoms, and both are poorly understood, says Dr Cope.
  • Direct to Consumer Wearables For Children: Who, What, When and How? This review explores direct to consumer wearables (D2CWs) and their use in pediatric and congenital heart disease patients — how to identify appropriate patients, what tools should be considered, implementation of device use, and management of acquired data.
  • Percutaneous LAA Closure in Patients With AF   What considerations are involved in percutaneous LAA closure in stroke risk management for patients with AF? Drs Ashish Bhimani and Sandeep Goyal examine the evidence.
  • STEMI Equivalents You've Got to Know The ACC formally recognizes decades of evidence supporting immediate reperfusion therapy for patients with MI and these ECG changes.
  • AHA 2022 Role of Ablation Type and Risk Factors in Paroxysmal AF   Jason Andrade gives details on the PROGRESSIVE-AF trial of cryoablation vs drugs in patients with paroxysmal AF, presented at the American Heart Association meeting.